Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic in talks to exit neuroradiology business via sale of Micro Interventional Systems.

This article was originally published in The Gray Sheet

Executive Summary

MEDTRONIC MISSES TARGET WITH MICRO INTERVENTIONAL SYSTEMS: the company says it is in talks to exit the neuroradiology business by divesting MIS. Medtronic announced its decision to sell MIS less than two years after it acquired the firm in November 1995 for about $73 mil. in Medtronic stock ("The Gray Sheet" Nov. 6, 1995, p. 6). Medtronic is casting the divestiture as a way to enable it to refocus resources on further developing the company's coronary and peripheral vascular product business.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008807

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel